Skip to main content
icon for Will Humana (HUM) beat quarterly earnings?
Einnahmen·Vor Neuem Ausblenden

Will Humana (HUM) beat quarterly earnings?

icon for Will Humana (HUM) beat quarterly earnings?
Einnahmen·Vor Neuem Ausblenden

Will Humana (HUM) beat quarterly earnings?

Juli 29

Juli 29

50% Chance
Polymarket
NEU
50% Chance
Polymarket
NEU
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Trader sentiment for Humana beating Q2 2026 earnings sits at an even 50% implied probability ahead of the July 29 release, reflecting balanced views on Medicare Advantage medical loss ratios and potential star-rating recovery. Q1 results showed a solid beat at $10.31 versus $9.97 expected, yet analysts maintain a consensus Hold rating with price targets clustered near $311–$321, citing ongoing pressures in the managed-care sector. Recent upgrades from Deutsche Bank and Mizuho highlight stabilizing enrollment and bonus-payment upside, but consensus 2026 EPS estimates near $9.02 underscore caution on margin expansion. The closely contested market hinges on whether July trends in utilization and plan positioning confirm these improvements or reveal further headwinds.

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Volumen
$0
Enddatum
29. Juli 2026
Markt eröffnet
Jul 15, 2026, 8:49 PM ET

Abwicklungsquelle

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Trader sentiment for Humana beating Q2 2026 earnings sits at an even 50% implied probability ahead of the July 29 release, reflecting balanced views on Medicare Advantage medical loss ratios and potential star-rating recovery. Q1 results showed a solid beat at $10.31 versus $9.97 expected, yet analysts maintain a consensus Hold rating with price targets clustered near $311–$321, citing ongoing pressures in the managed-care sector. Recent upgrades from Deutsche Bank and Mizuho highlight stabilizing enrollment and bonus-payment upside, but consensus 2026 EPS estimates near $9.02 underscore caution on margin expansion. The closely contested market hinges on whether July trends in utilization and plan positioning confirm these improvements or reveal further headwinds.

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Volumen
$0
Enddatum
29. Juli 2026
Markt eröffnet
Jul 15, 2026, 8:49 PM ET

Abwicklungsquelle

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Verwandte

icon for Werden die Milwaukee Brewers den NL Central Titel 2026 gewinnen?

Werden die Milwaukee Brewers den NL Central Titel 2026 gewinnen?

78%
Ja
icon for Saturn FDV above $50M one day after launch

Saturn FDV above $50M one day after launch

79%
icon for Will Germany GDP growth in Q2 2026 be between 0.4% and 0.6%?

Will Germany GDP growth in Q2 2026 be between 0.4% and 0.6%?

44%

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Will Humana (HUM) beat quarterly earnings?" ist ein Prognosemarkt auf Polymarket, auf dem Händler „Ja"- oder „Nein"-Anteile kaufen und verkaufen, je nachdem, ob sie glauben, dass dieses Ereignis eintreten wird. Die aktuelle Wahrscheinlichkeit laut Community liegt bei 50% für „Yes". Wird „Ja" beispielsweise bei 50¢ gehandelt, schätzt der Markt die Wahrscheinlichkeit des Eintretens auf 50%. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen und Informationen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

„Will Humana (HUM) beat quarterly earnings?" ist ein neu erstellter Markt auf Polymarket, gestartet am Jul 15, 2026. Als früher Markt haben Sie die Gelegenheit, zu den ersten Händlern zu gehören, die die Quoten setzen und die ersten Preissignale des Marktes etablieren. Sie können diese Seite auch als Lesezeichen speichern, um Volumen und Handelsaktivität zu verfolgen, während der Markt an Fahrt gewinnt.

Um auf „Will Humana (HUM) beat quarterly earnings?" zu handeln, wählen Sie einfach, ob Sie glauben, dass die Antwort „Ja" oder „Nein" lautet. Jede Seite hat einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes widerspiegelt. Geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Wenn Sie „Ja"-Anteile kaufen und das Ergebnis als „Ja" aufgelöst wird, zahlt jeder Anteil $1 aus. Wird es als „Nein" aufgelöst, zahlen Ihre „Ja"-Anteile $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen, um einen Gewinn zu sichern oder einen Verlust zu begrenzen.

Die aktuelle Wahrscheinlichkeit für „Will Humana (HUM) beat quarterly earnings?" liegt bei 50% für „Yes". Das bedeutet, die Polymarket-Community glaubt derzeit, dass eine Wahrscheinlichkeit von 50% besteht, dass dieses Ereignis eintritt. Diese Quoten werden in Echtzeit auf Basis tatsächlicher Handelsgeschäfte aktualisiert und liefern ein ständig aktualisiertes Signal dessen, was der Markt erwartet.

Die Auflösungsregeln für „Will Humana (HUM) beat quarterly earnings?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.